Moderna has been in discussions to sell its Covid shot in Europe, where Pfizer Inc. and its partner, BioNTech, already have a deal in place. Based on recent discussions, Moderna said it now expects "very low" sales in the region. The company also cut its revenue guidance for the year because some international sales are tied to vaccination rates and may be deferred to next year, according to Mock.